-
Daiichi Sankyo begins patient dosing in TROPION─Lung07 phase 3 trial to evaluate datopotamab deruxtecan in combo with pembrolizumab to treat patients with previously untreated metastatic NSCLC
31 Jan 2023 13:48 GMT
… advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) … with non-small cell lung cancer, across PD-L1 segments … Europe, Asia and Oceania.
Lung cancer is the second most common … is expressed across all lung cancer subtypes with the highest …
-
Addition of serplulimab to chemotherapy extends OS in small cell lung cancer
31 Jan 2023 00:54 GMT
… extensive-stage small cell lung cancer, according to randomized phase … for approximately 15% of lung cancer cases. Most patients present … extensive-stage small cell lung cancer. The analysis included … study participants with brain metastases and the short …
-
TROPION-Lung07 Phase 3 Trial Initiated to Evaluate Datopotamab Deruxtecan in Combination with Pembrolizumab in Patients with Previously Untreated Metastatic Non-Small Cell Lung Cancer
30 Jan 2023 13:19 GMT
… advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) … with non-small cell lung cancer, across PD-L1 … Small Cell Lung Cancer Without Actionable Genomic Alterations
Lung cancer is the … is expressed across all lung cancer subtypes with the …
-
Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer
30 Jan 2023 09:43 GMT
… IIIA non-small cell lung cancer. Unfortunately, many of … with non-small cell lung cancer following surgery and adjuvant … metastatic non-small cell lung cancer and has changed the way metastatic … with non-small cell lung cancer.”
"With this approval …
-
Reprogramming lung cancer cells can revert metastasis: KAIST
30 Jan 2023 04:47 GMT
… change the properties of lung cancer cells to revert metastasis and lower drug … can reprogram lung cancer cells to remove high plasticity and metastatic ability and … by successfully reversing lung cancer cells with the high metastatic ability and drug …
-
Guardant Health receives FDA approval for Guardant360® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer
30 Jan 2023 12:10 GMT
… to identify advanced or metastatic breast cancer patients … ESR1-mutated, advanced or metastatic breast cancer with disease progression … with non-small cell lung cancer who may benefit from … emerging clinical biomarker in metastatic hormone receptor-positive …
-
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases
30 Jan 2023 02:18 GMT
… million deaths were from lung cancers, making it the most … rate of most current lung cancer drugs, lung cancers metastasized to the CNS … be a refuge for lung cancer cells. Zorifertinib is a … NSCLC patients with CNS metastases and EGFR-sensitizing mutations. …
-
Merck's KEYTRUDA Gets FDA Approval To Treat Stage IB, II, IIIA Non-small Cell Lung Cancer Patients
27 Jan 2023 12:31 GMT
… or IIIA non-small cell lung cancer or NSCLC.
With this … in both the adjuvant and metastatic settings, the company noted. … of metastatic non-small cell lung cancer and has changed the way metastatic … in non-small cell lung cancer and the first indication …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:12 GMT
… -small cell lung cancer following surgery … metastatic non-small cell lung cancer and has changed the way metastatic … (ETOP).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:06 GMT
… -small cell lung cancer following surgery … metastatic non-small cell lung cancer and has changed the way metastatic … (ETOP).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer …
About
© 1995-2023